Safety and Efficacy Study of Recombinant Human Lactoferrin to Treat Severe Sepsis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kalpalatha K Guntupalli, MD
Baylor College of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Vancouver General Hospital
Vancouver, British Columbia, Canada
- Kingston General Hospital
Kingston, Ontario, Canada
- Centre Hospitalier de Montauban
Montauban, France
- Centre Hospitalier Angouleme
Saint-Michel, France
- Helios Klinikum Erfurt
Erfurt, Germany
- Hospital de Sabadell
Sabadell, Catalonia, Spain
- Hospital Mutua de Terrassa
Terrassa, Catalonia, Spain
- Loma Linda University Medical Center
Loma Linda, California, United States
- Uc Davis Medical Center
Sacramento, California, United States
- Olive View- Ucla Medical Center
Sylmar, California, United States
- Denver Health Medical Center
Denver, Colorado, United States
- the George Washington University Hospital
Washington D.C., District of Columbia, United States
- Rush University Medical Center
Chicago, Illinois, United States
- West Suburban Medical Center
Oak Park, Illinois, United States
- Floyd Memorial Hospital and Health Services
New Albany, Indiana, United States
- University of Iowa Hospitals and Clinic
Iowa City, Iowa, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Baystate Medical Center
Springfield, Massachusetts, United States
- Henry Ford Health System
Detroit, Michigan, United States
- St. John'S Mercy Medical Center
St Louis, Missouri, United States
- St. Louis University
St Louis, Missouri, United States
- Cooper University Hospital
Camden, New Jersey, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Wake Forest University Baptist Medical Center
Winston-Salem, North Carolina, United States
- Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
- University of Oklahoma Health Science Center
Oklahoma City, Oklahoma, United States
- University of Pittsburgh Medical Center Presbyterian Hospital
Pittsburgh, Pennsylvania, United States
- Rhode Island Hospital
Providence, Rhode Island, United States
- Texas Tech University Health Sciences Center
El Paso, Texas, United States
- Ben Taub General Hospital
Houston, Texas, United States
- the Methodist Hospital
Houston, Texas, United States
- the University of Texas Md Anderson Cancer Center
Houston, Texas, United States
- Scott & White Memorial Hospital
Temple, Texas, United States
- Intermountain Medical Center
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2008
- Primary completion
- 31 Aug 2009
- Completion
- 28 Feb 2010
- Last update posted
- 23 Aug 2011
- Registered enrollment
- 190
- Registry id
- NCT00630656
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.